GI
XBI icon

GAMMA Investing’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

GAMMA Investing’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$92.9K Hold
589
– – ﹤0.01% 1927
2026
Q2 		$93.2K Buy
589
+530
+898% +$71.6K ﹤0.01% 1858
2026
Q1 		$7.54K Buy
59
+51
+638% +$6.37K ﹤0.01% 3205
2025
Q4 		$975 Hold
8
– – ﹤0.01% 3797
2025
Q3 		$802 Buy
+8
New +$721 ﹤0.01% 3647
2025
Q2 		– Sell
-260
Closed -$21.1K – 3898
2025
Q1 		$21.1K Sell
260
-72
-22% -$6.43K ﹤0.01% 2350
2024
Q4 		$29.9K Sell
332
-759
-70% -$73.5K ﹤0.01% 2040
2024
Q3 		$108K Buy
1,091
+1,076
+7,173% +$106K 0.01% 948
2024
Q2 		$1.39K Hold
15
– – ﹤0.01% 2983
2024
Q1 		$1.42K Sell
15
-10
-40% -$928 ﹤0.01% 2856
2023
Q4 		$2.19K Buy
+25
New +$1.86K ﹤0.01% 2555

Other funds holding XBI

LHWM
Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return
AIC
Ayalon Insurance Company Ramat Gan, Israel $1.2B AUM 25.57% 1-Year Est. Return
MWA
MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return
MAM
Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BCG
Breakwater Capital Group Paramus, New Jersey $844M AUM 15.36% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
WAM
Worth Asset Management Dallas, Texas $343M AUM 29.82% 1-Year Est. Return

GAMMA Investing's XBI Position: Q3 2026 in Review

GAMMA Investing held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 589 shares worth $92.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1927.

GAMMA Investing first reported a position in XBI in Q4 2023 and has held it in 11 quarters since. The position peaked at $108K in Q3 2024. 39 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • GAMMA Investing held 589 shares of State Street SPDR S&P Biotech ETF worth $92.9K as of Q3 2026.
  • GAMMA Investing left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1927 holding.
  • GAMMA Investing first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's State Street SPDR S&P Biotech ETF position peaked at $108K in Q3 2024.
  • 39 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.